Orthotopic liver transplantation for cholestatic diseases

Hepato-Gastroenterology

Volumn 57, Issue 99-100, 2010, Pages 605-610

  Patkowski, Waldemar ^a   Skalski, M ^a   Zieniewicz, K ^a   Nyckowski, P ^a   Smoter, P ^a   Krawczyk, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cholestatic; Orthotopic liver transplant

Indexed keywords

ACUTE PANCREATITIS; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ATELECTASIS; BILE DUCT CARCINOMA; BILE DUCT INJURY; BILE LEAKAGE; BILIARY CIRRHOSIS; CANCER RECURRENCE; CAROLI DISEASE; CHOLESTASIS; CYSTIC FIBROSIS; ECHINOCOCCOSIS; FEMALE; HEMATOMA; HEMOPERITONEUM; HEPATIC ARTERY; HUMAN; IATROGENIC DISEASE; LAPAROTOMY; LIVER ABSCESS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORTHOTOPIC TRANSPLANTATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REOPERATION; SECONDARY BILIARY CIRRHOSIS; SEPSIS; TREATMENT FAILURE; WOUND INFECTION;

ADULT; AGED; CAROLI DISEASE; CHOLANGITIS, SCLEROSING; CHOLESTASIS; CYSTIC FIBROSIS; ECHINOCOCCOSIS, HEPATIC; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77955500551     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. st Wintermeeting ELTR-ELTA, Obergurgl, Austria, 2005.
2. Nyckowski P, Pawlak J, Skwarek A, et al: Transplantacja wa̧troby w chorobach cholestatycznych. Gastroenterologie Polska 2003,10; 255-258.
3. Pratschke J, Steinmuller T, Bechstein WO, et al: Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplant 1998,12; 228-232.
4. Lamireau T, Monnereau S, Martin S, et al: Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 2004, 41; 920-925.
5. Colombo C, Battezzati PM, Crosignani A, et al: Liver Disease in Cystic Fibrosis: A Prospective Study on Incidence, Risk Factors, and Outcome. Hepatology 2002, 36; 1374-1382.
6. Gines P: Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7: 122-128
7. Saunders B: 20-year prospective study of cirrhosis. Br Med J 1981;282:263-266
8. Gines P, Quintero E, Arroyo V I wsp: Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128
9. Ziser A, Plevak D.J, Wiesner R.H: Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90: 42-53
10. Aranha G.V, Sontag S.J, Greenlee H.B: Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg 1982; 143: 55-60
11. Aranha G.V, Greenlee H.B: Intraabdominal surgery in patients with advanced cirrhosis. Arch Surg 1986; 121: 275-277
12. McDiarmid S, Gish R.G, Horslen S. i wsp: Model for End-Stage Liver Disease (MELD). Exception for Unusual Metabolic Liver Diseases. Liver Transpl 2006; 12: S124-S127
13. Sheiner P, Gish R.G, Sanyal A: Model for End-Stage Liver Disease (MELD). Exception for Portal Hypertensive Gastrointestinal Bleeding. Liver Transpl 2006; 12: S112-S113
14. Bardadin K.A: Patomechanizm zmian morfologicznych w zakażeniach wirusem hepatitis C. Hepatologia 2002; 2: 25-36
15. Washburn W.K, Gis R.G: Model for End-Stage Liver Disease (MELD). Exception for Severe Pruritus. Liver Transpl 2006; 12: S119
16. Ham J, Gish R.G, Mullen K: Model for End-Stage Liver Disease (MELD). Exception for Hepatic Encephalopathy. Liver Transpl 2006; 12: S102-S104
17. Hasse J.M, Blue L.S, Liepa G.U. i wsp: Early enteral nutrition support in patients undergoing liver transplantation. Journal of Parenteral and Enteral Nutrition 1995, 19: 437-441
18. Rayes N, Seehofer D, Theruvath T. i wsp: Supply of Pre- and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation - A Randomized, Double-Blind Trial. Am J Transplant 2005; 5: 125-130
19. Muller M.J, Loyal S, Schwarze M i wsp: Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation. Clinical Nutrition 1994; 13: 145-149
20. Plauth M, Meri M, Kondrup J. i wsp: ESPEN guidelines for nutrition in liver disease and transplantation. Consensus statement. Clinical Nutrition 1997; 16: 43-47
21. Porayko M.K, DiCecco S, O'Keefe S.J.D: Impact of malnutrition and its therapy on liver transplantation. Semin Liver Dis 1991; 11: 305-310
22. Gores G.J, Gish R.G, Shrestha R. i wsp: Model for End-Stage Liver Disease (MELD). Exception for Bacterial Cholangitis. Liver Transpl 2006; 12: S91-S92
23. Neuberger J, Gunson B, Hubscher S. i wsp: Immunosuppression Affects the Rate of Recurrent Primary Biliary Cirrhosis after Liver Transplantation. Liver Transpl 2004; 10: 488-491
24. Neuberger J: Recurrent Primary Biliary Cirrhosis. Liver Transpl 2003; 9: 539-546
25. Nyckowski P, Pawlak J, Skwarek A. i wsp: Transplantacja wa̧troby w chorobach cholestatycznych. Gastroenterologia Polska 2003; 10: 255-258
26. Brandsaeter B, Schrumpf E, Bentdal O. i wsp: Recurrent Primary Sclerosing Cholangitis after Liver Transplantation: A Magnetic Resonance Cholangiography Study with Analyses of Predictive Factors. Liver Transpl 2005; 11: 1361-1369
27. Bjoro K, Schrumpf E: Liver transplantation for primary sclerosing cholangitis. J Hepatol 2004; 40: 570-577
28. Graziadei LW, Wiesner R.H, Batts K.P. i wsp: Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation. Hepatology 1999; 29: 1050-1056
29. Jain A, Reyes J, Kashyap R i wsp: Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg 2000, 232; 490-500.
30. Gabriel A. Marskość W, włóknienie i stłuszczenie: W Hepatologia. Kompedium. Red. Jerzy Polański. Wydanie pierwsze, 2004, 41-46.
31. Nordin A, Halme L, Makisalo H. i wsp: Management and Outcome of Major Bile Duct Injuries After Laparoscopic Cholecystectomy: From Therapeutic Endoscopy to Liver Transplantation. Liver Transplantation 2002, 11; 1036-1043.
32. Genyk Y.S, Quiros J.A, Jabbour N. i wsp: Liver transplantation in cystic fibrosis. Curr Opin Pulm Med 2001; 7: 441-447
33. Couetil J.P, Houssin D.P, Soubrane O. i wsp: Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1995; 110: 1415-1422
34. Couetil J.P, Soubrane O, Houssin D.P. i wsp: Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997; 10: 33-39
35. Horslen S, Sweet S, Gish R.G. i wsp: Model for EndStage Liver Disease (MELD). Exception for Cystic Fibrosis. Liver Transpl 2006; 12: S98-S99
36. Noble - Jamieson G, Thiru S, Johnston P. i wsp: Glomerulonephritis with end-stage liver disease in childhood. Lancet 1992; 339: 706-707
37. Noble - Jamieson G, Valente J, Barnes N.D. i wsp: Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Child 1994, 71: 394-352
38. Fridell JA, Bond G.J, Mazariegos G.V. i wsp: Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg 2003; 38: 1152-1156
39. Kern P, Bardonnet K, Renner E, et al: European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis, 2003; 9: 320-341.
40. Tagliacozzo S: Management of hydatid disease of the liver. Surgical Management of Hepatobiliary and Pancreatic disorders. Red. Poston G.J, Blumgart L.H, London and New York, 2003: 215-235.
41. Mueller L, Broering DC, Vashist Y, et al: A Retrospective Study Comparing the Different Surgical Procedures for the Treatment of Hydatid Disease of the Liver. Dig Surg, 2003; 20: 279-284.
42. Markmann J.F, Gornbein J, Markowitz J.S. i wsp: A simple model to estimate survival after retransplantation of the liver. Transplantation 1999; 67: 422-430
43. Watt K.D.S., Lyden M.E, McCashland: Mortality While Awaiting Liver Retransplantation: Predictability of MELD Scores. Transplant Proc 2005; 37: 2172-2173